Effect of Hydralazine on Methylation and Expression of RUNX3 Gene in Human Gastric Cancer Cell Lines

LIN Hai,CAO Jun,ZHANG Bin,CHEN Min,WU Yumei,ZOU Xiaoping
DOI: https://doi.org/10.3969/j.issn.1008-7125.2010.02.003
2010-01-01
Abstract:Background:Silencing of tumor suppressor gene RUNX3 by aberrant methylation is a crucial mechanism in the development of gastric cancer.Restoring the expression of RUNX3 by demethylation agents might achieve an anti-tumor effect.Aims:To investigate the effect of demethylation agent hydralazine on RUNX3 gene methylation and expression in human gastric cancer cell lines,and its influence on growth and apoptosis of gastric cancer cells.Methods:RUNX3 mRNA expression and methylation status in SGC7901,MKN28 and MGC803 cells were examined by RT-PCR and methylation-specific PCR (MSP) prior to and after hydralazine and 5-Aza-dC treatment.MTT and flow cytometry assays were used to observe the changes of proliferation activity,cell cycle,and apoptosis of MKN28 cells.Results:RUNX3 gene was silenced in MKN28 cells as a result of hypermethylation.After treated with 40 μmol/L hydralazine for 72 hours, unmethylated band representing partial demethylation could be detected in MKN28 cells,and the expression of RUNX3 mRNA was restored.The expression level of RUNX3 mRNA in hydralazine group,however,was inferior to 5-Aza-dC group (P<0.05).Proliferation inhibition,cell cycle arrest in G0/G1 phase and apoptosis could be observed in MKN28 cells when the dosage of hydralazine ≥10 μmol/L (P<0.05).Conclusions:Hydralazine restores RUNX3 gene expression by demethylation,and inhibits proliferation,induces apoptosis in MKN28 cells.The use of hydralazine in the treatment of gastric cancer is worthy of further investigation.
What problem does this paper attempt to address?